Edition:
United Kingdom

Healthscope Ltd (HSO.AX)

HSO.AX on Australia Stock Exchange

2.07AUD
21 Sep 2018
Change (% chg)

$-0.04 (-1.90%)
Prev Close
$2.11
Open
$2.11
Day's High
$2.12
Day's Low
$2.07
Volume
33,366,837
Avg. Vol
4,733,003
52-wk High
$2.59
52-wk Low
$1.64

Chart for

About

Healthscope Limited is a healthcare provider. The Company is engaged in the provision of healthcare services through the ownership and management of hospitals and medical centers, and the provision of pathology diagnostic services. The Company's segments include Hospitals Australia, Pathology New Zealand, and Other. The... (more)

Overall

Beta: --
Market Cap(Mil.): $3,146.06
Shares Outstanding(Mil.): 1,738.15
Dividend: 0.04
Yield (%): 3.87

Financials

  HSO.AX Industry Sector
P/E (TTM): 19.38 28.54 32.76
EPS (TTM): 0.09 -- --
ROI: 3.89 6.84 14.61
ROE: 6.86 10.73 16.33

Deals of the day-Mergers and acquisitions

Aug 21 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

21 Aug 2018

Australia's Healthscope to spin off hospitals as patient exodus hits profits

SYDNEY Australian hospital operator Healthscope , which recently rejected two takeover approaches, plans to inject A$1 billion ($731.6 million) of its property assets into a trust and sell nearly half of that to an investor.

21 Aug 2018

UPDATE 2-Australia's Healthscope to spin off hospitals as patient exodus hits profits

* Operating profit halves, in line with own expectations (Adds background and analyst comment, response from previous suitors, share move)

21 Aug 2018

Australia's Healthscope to form unlisted hospital property trust

Aug 21 Australia's Healthscope said on Tuesday it would establish a new unlisted property trust after it concluded a strategic review of its hospital property assets.

21 Aug 2018

Australia's Healthscope to sell Asian pathology operations

SYDNEY Australian hospital operator Healthscope Ltd said it would sell its Asian pathology business to private equity giant TPG Capital Management LP [TPG.UL] to cut debt and bankroll growth plans, months after rejecting two buyout approaches.

30 Jul 2018

UPDATE 2-Australia's Healthscope to sell Asian pathology operations

SYDNEY, July 30 Australian hospital operator Healthscope Ltd said it would sell its Asian pathology business to private equity giant TPG Capital Management LP to cut debt and bankroll growth plans, months after rejecting two buyout approaches.

30 Jul 2018

Australia's Healthscope to sell Asian pathology operations

July 30 Australian hospital group Healthscope Ltd said on Monday it will sell its Asian pathology business for A$279 million ($206.5 million) to entities controlled by funds which are managed by TPG Capital Asia.

30 Jul 2018

Goldman to review bookbuilding after Australia regulator blasts block trade

SYDNEY Goldman Sachs has agreed to review how it sells shares to investors in Australia, after the country's corporate regulator penalized its local arm for failing to notify the market about dwindling interest in a block trade it conducted in 2015.

02 Jul 2018

UPDATE 1-Goldman to review bookbuilding after Australia regulator blasts block trade

* Second action against global investment bank in Australia in a month

02 Jul 2018

Goldman to review bookbuilding after Healthscope block query -Australia regulator

SYDNEY, July 2 Australia's corporate regulator said the local arm of Goldman Sachs has agreed to review how it sells shares to investors, after it failed to notify the market about dwindling interest in a block trade it conducted for Healthscope in 2015.

02 Jul 2018

Earnings vs. Estimates